Brighton Jones LLC’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-2,889
Closed -$459K – 603
2023
Q3
$459K Sell
2,889
-76
-3% -$12.4K 0.02% 307
2023
Q2
$419K Sell
2,965
-5
-0.2% -$802 0.02% 330
2023
Q1
$500K Buy
+2,970
New +$530K 0.03% 287

Other funds holding RGEN

Brighton Jones LLC's RGEN Position: Q4 2023 in Review

Brighton Jones LLC sold out of Repligen (RGEN) in Q4 2023, closing a stake of 2,889 shares — an estimated $459K sold.

Brighton Jones LLC first reported a position in RGEN in Q1 2023 and held it in 3 quarters. The position peaked at $500K in Q1 2023. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.

  • Brighton Jones LLC reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
  • Brighton Jones LLC sold 2,889 Repligen shares in Q4 2023, an estimated $459K.
  • Brighton Jones LLC first reported a position in Repligen in Q1 2023 and held it in 3 quarters.
  • Brighton Jones LLC's Repligen position peaked at $500K in Q1 2023.
  • 466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.

Based on Brighton Jones LLC's 13F filing for Q4 2023, filed 5 Feb 2024.